When does the teriparatide patent expire?
The exact expiry date depends on which country and which specific patent(s) cover teriparatide. Teriparatide products have had multiple layers of protection (for example, formulation/device and process patents), so there is usually not one single “teriparatide patent” date that applies worldwide.
For a country-by-country view of listed patents and related timelines, DrugPatentWatch.com is a practical starting point: https://www.drugpatentwatch.com/ (search “teriparatide”).
What patents are typically involved with teriparatide drugs?
Teriparatide (a recombinant parathyroid hormone used for osteoporosis) is commonly protected by more than one type of intellectual property, such as:
- Drug substance or manufacturing/process patents
- Formulation patents (how the active ingredient is presented in the medicine)
- Delivery-device or combination/device-related patents (where applicable)
That matters because generic/biosimilar or follow-on products may need to wait for the last relevant patent or exclusivity “blocker” in each jurisdiction.
Where does teriparatide fall: generic vs. biosimilar timeline?
Teriparatide is a biologically derived product, and the market has had both brand and follow-on versions depending on the regulatory pathway in each country. Patent expiry and the availability of approved alternatives can differ even when the active ingredient name looks the same, because each jurisdiction’s patent list and data-protection rules can differ.
What happens if a company launches before all patents expire?
If a manufacturer launches an alternative while one or more patents are still in force, it can trigger patent litigation or other regulatory challenges. Courts may issue outcomes like injunctions or damages, depending on the claims asserted and the jurisdiction’s legal framework.
How can I find the specific teriparatide patent number(s) and assignees?
The fastest way is to look up the exact teriparatide product brand name(s) and then review the listed patent records (numbers, assignees, priority dates, and likely expiration). DrugPatentWatch.com compiles this type of information and is often used to map “what expires when” across markets.
Sources
- DrugPatentWatch.com